At a glance
ClinicalIndex Comparison RecordN/ACompleted· 479 enrolled
Drug / intervention
Blood culture identification panelother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Impact of a Multiplex PCR Blood Culture Identification Panel in Early Identification of Positive Blood Cultures in Pediatric Patients in Guatemala
In Brief
A clinical study evaluating Blood culture identification panel for Bacteremia and Sepsis. Completed, enrolled 479 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the clinical impact of a rapid multiplex PCR blood culture identification panel on time to optimal antimicrobial therapy when compared to conventional microbiological culture methods in children hospitalized in a low resource setting in Guatemala City.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacteremia, Sepsis
CountriesGuatemala
CollaboratorsBioFire Diagnostics, LLC
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartApr 2022
Primary CompletionNov 2022
Study CompletionNov 2022
TodayJul 2026
First PostedApr 6, 2022
Enrollment StartApr 7, 2022
Primary CompletionNov 11, 2022
Study CompletionNov 28, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.2 years ago
Interventions
Blood culture identification panelother
multiplex PCR panel to be performed on positive blood cultures